These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34405740)

  • 41. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.
    Patsalos PN
    Epilepsia; 2005; 46 Suppl 9():140-8. PubMed ID: 16302888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidose activated charcoal in the treatment of carbamazepine overdose with seizures: a case report.
    Mise S; Jukić I; Tonkić A; Titlić M; Mise S
    Arh Hig Rada Toksikol; 2005 Dec; 56(4):333-8. PubMed ID: 16370516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses.
    Campos MSA; Ayres LR; Morelo MRS; Carizio FAM; Pereira LRL
    Int J Clin Pharm; 2018 Jun; 40(3):589-598. PubMed ID: 29744790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple-dose pharmacokinetics of cenerimod and the effect of charcoal on its elimination.
    Mueller MS; Juif PE; Charfi H; Dingemanse J
    J Clin Pharmacol; 2024 Dec; 64(12):1566-1575. PubMed ID: 39141427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of multi-dose activated charcoal in phenytoin toxicity secondary to genetic polymorphism.
    Chan BS; Sellors K; Chiew AL; Buckley NA
    Clin Toxicol (Phila); 2015 Feb; 53(2):131-3. PubMed ID: 25597548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-poisoning with theophylline. The effect of repeated doses oral charcoal on drug elimination.
    Rygnestad T; Walstad RA; Dahl K
    Acta Med Scand; 1986; 219(4):425-7. PubMed ID: 3716886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of phenytoin toxicity with repeated doses of activated charcoal.
    Weichbrodt GD; Elliott DP
    Ann Emerg Med; 1987 Dec; 16(12):1387-9. PubMed ID: 3688606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
    Eriksson AS; Hoppu K; Nergårdh A; Boreus L
    Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity.
    Isbister GK; Hackett LP; Dawson AH; Whyte IM; Smith AJ
    Br J Clin Pharmacol; 2003 Oct; 56(4):441-50. PubMed ID: 12968990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of side effects on long-term retention in three new antiepileptic drugs.
    Bootsma HP; Ricker L; Hekster YA; Hulsman J; Lambrechts D; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2009 Jun; 18(5):327-31. PubMed ID: 19110447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
    Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI
    Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Woolf AD; Erdman AR; Nelson LS; Caravati EM; Cobaugh DJ; Booze LL; Wax PM; Manoguerra AS; Scharman EJ; Olson KR; Chyka PA; Christianson G; Troutman WG
    Clin Toxicol (Phila); 2007; 45(3):203-33. PubMed ID: 17453872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Use of Activated Charcoal to Treat Intoxications.
    Zellner T; Prasa D; Färber E; Hoffmann-Walbeck P; Genser D; Eyer F
    Dtsch Arztebl Int; 2019 May; 116(18):311-317. PubMed ID: 31219028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy.
    Siniscalchi A; Gallelli L; Calabrò G; Tolotta GA; De Sarro G
    Ann Pharmacother; 2010 Dec; 44(12):2031-4. PubMed ID: 21098752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lamotrigine versus vigabatrin as an add-on therapy in refractory epilepsy: prospective study].
    Maciejek Z; Niezgodzińska-Maciejek A
    Neurol Neurochir Pol; 2000; 34 Suppl 1():165-75. PubMed ID: 10768156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The frequency of complications associated with the use of multiple-dose activated charcoal.
    Dorrington CL; Johnson DW; Brant R;
    Ann Emerg Med; 2003 Mar; 41(3):370-7. PubMed ID: 12605204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.
    Neuvonen PJ; Olkkola KT
    Med Toxicol Adverse Drug Exp; 1988; 3(1):33-58. PubMed ID: 3285126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Epileptic seizures during childbirth in a patient with idiopathic generalised epilepsy].
    Voermans NC; Zwarts MJ; Renier WO; Bloem BR
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1406-11. PubMed ID: 15997694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lamotrigine serum concentration in children with epilepsy.
    Heyman E; Lavie R; Lahat E; Braunstein R; Bar-Haim A; Berkovitch M; Gandelman-Marton R
    Pediatr Neurol; 2012 Dec; 47(6):427-30. PubMed ID: 23127263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.